Showing results (2581-2590 of 2,757) with videos related to
Sort By:
Pageof 276
Immunity|December 29, 2022
Small intestine and colon tissue-resident memory CD8+ T cells exhibit molecular heterogeneity and differential dependence on EomesYun Hsuan Lin, Han G Duong, Abigail E Limary, et al.American Journal of Public Health|January 18, 2014
Body mass index and risk of death in Asian AmericansYikyung Park, Sophia Wang, Cari M Kitahara, et al.The New England Journal of Medicine|April 21, 2021
Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant PersonsTom T Shimabukuro, Shin Y Kim, Tanya R Myers, et al.The New England Journal of Medicine|October 21, 2020
Anti-Siglec-8 Antibody for Eosinophilic Gastritis and DuodenitisEvan S Dellon, Kathryn A Peterson, Joseph A Murray, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2017
Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct PathogenesisMatthew T Chang, Alexander Penson, Neil B Desai, et al.Cell Genomics|February 15, 2024
Host genetic variants, Epstein-Barr virus subtypes, and the risk of nasopharyngeal carcinoma: Assessment of interaction and mediationMiao Xu, Ruimei Feng, Zhonghua Liu, et al.Proceedings of the National Academy of Sciences of the United States of America|April 27, 2016
Remarkably low affinity of CD4/peptide-major histocompatibility complex class II protein interactionsPeter Jönsson, Jennifer H Southcombe, Ana Mafalda Santos, et al.The British Journal of Ophthalmology|October 19, 2023
Developing a privacy-preserving deep learning model for glaucoma detection: a multicentre study with federated learningAn Ran Ran, Xi Wang, Poemen P Chan, et al.Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 31, 2013
Development of a consumer product ingredient database for chemical exposure screening and prioritizationM-R Goldsmith, C M Grulke, R D Brooks, et al.Cancer|December 25, 2014
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinomaJoseph M Herman, Daniel T Chang, Karyn A Goodman, et al.Pageof 276